Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D.
Let’s start with two questions today:
What deadly infectious disease continues to kill up to 1.5 million people each year and continues to mutate and evolve into forms that are increasingly hard to treat? And especially impacts countries with weak health systems? No, it’s not what you’re thinking! I’m talking about tuberculosis and the continued increase in the number of people suffering from drug-resistant TB.